An advisory committee to the U.S. Food and Drug Administration held a virtual meeting Thursday to discuss what data would be needed to vaccinate children under 12 against COVID. As The BMJ's Senior Editor Peter Doshi said during the meeting, vaccinating children for the benefit of adults is an “unproven hypothetical benefit.” Click here to read The Defender's coverage of the meeting.